Dihydroxanthyletin

Dihydroxanthyletin

SCHEMBL4741095

CC1(C)CCc2cc3ccc(=O)oc3cc2O1

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 4/20 0.60
▸ ACHE P22303 3/20 0.60
▸ MGAM O43451 1/20 0.60
▸ SI P14410 1/20 0.60
▸ PTPN1 P18031 1/20 0.60
▸ MGAM2 Q2M2H8 1/20 0.60
▸ ALDH1A1 P00352 7/20 0.50
▸ KDM4E B2RXH2 6/20 0.50
▸ HPGD P15428 6/20 0.50
▸ HSD17B10 Q99714 4/20 0.50
▸ NPC1 O15118 3/20 0.50
▸ RAB9A P51151 3/20 0.50
▸ CA9 Q16790 3/20 0.50
▸ CA12 O43570 2/20 0.50
▸ MAPT P10636 2/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ CA1 P00915 1/20 0.50
▸ TP53 P04637 1/20 0.50
▸ POLB P06746 1/20 0.50
▸ CA7 P43166 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9464004 0.82 GAA (0.53) GAAACHEMGAMSIPTPN1
SCHEMBL23302557 0.78 GAA (0.61) GAAACHEMGAMSIPTPN1
SCHEMBL4744447 0.78 GAA (0.61) GAAACHEMGAMSIPTPN1
SCHEMBL9463889 0.76 ALDH2 (0.60) GAAALDH1A1KDM4EHPGDHSD17B10
Decursinol SCHEMBL18845442 0.75 GAA (1.00) GAAACHEMGAMSIPTPN1
Decursinol SCHEMBL29517185 0.75 GAA (1.00) GAAACHEMGAMSIPTPN1
Decursinol SCHEMBL30034733 0.75 GAA (1.00) GAAACHEMGAMSIPTPN1
Decursinol SCHEMBL14105325 0.75 GAA (1.00) GAAACHEMGAMSIPTPN1
SCHEMBL14105337 0.75 GAA (0.76) GAAACHEMGAMSIPTPN1
Decursinol SCHEMBL3895912 0.75 GAA (1.00) GAAACHEMGAMSIPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120277297-A1 Pharmaceutical Composition Useful as Acetylcholinesterase Inhibitors COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2012-11-01 — — US claimed
EP-2001463-A1 A PHARMACEUTICAL COMPOSITION USEFUL AS ACETYL CHOLINESTERASE INHIBITORS Council of Scientific and Industrial Research (IN) 2008-12-17 — — EP claimed
WO-2008102994-A1 COMPOSITION COMPRISING DECURSIN DERIVATIVE FOR TREATING AND PREVENTING ATOPIC DERMATITIS PARK YONG JIN (KR) 2008-08-28 — — WO claimed
US-20080009544-A1 Pharmaceutical Composition Useful as Acetylcholinesterase Inhibitors COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2008-01-10 — — US claimed
WO-2007107846-A1 A PHARMACEUTICAL COMPOSITION USEFUL AS ACETYL CHOLINESTERASE INHIBITORS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2007-09-27 — — WO claimed
WO-1990008529-A2 7-ALKOXYCOUMARINS, DIHYDROPSORALENS, AND BENZODIPYRANONES AS PHOTO-ACTIVATED THERAPEUTIC AGENTS AND INHIBITORS OF EPIDERMAL GROWTH FACTOR LEHIGH UNIVERSITY (US) 1990-08-09 — — WO claimed
WO-2024172513-A1 NOVEL DECURSIN DERIVATIVE AND USE THEREOF FOR PREVENTING OR TREATING NON-SMALL CELL LUNG CANCER (주)재인알앤피 2024-08-22 — — WO disclosed
WO-2022154356-A1 COMPOSITION COMPRISING (7S)-(+)-CYCLOPENTYL CARBARMIC ACID, 8,8-DIMETHYL-2-OXO-6,7-DIHYDRO-2H,8H-PYRANO[3,2-G]CHROMEN-7-YL-ESTER AS ACTIVE INGREDIENT FOR PREVENTION, ALLEVIATION, OR TREATMENT OF EYE DISEASE 국민대학교 산학협력단 2022-07-21 — — WO disclosed
US-20170129904-A1 NEW COMPOUND FOR INHIBITING BINDING BETWEEN DX2 PROTEIN AND P14/ARF PROTEIN, AND PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING CANCER DISEASE CONTAINING SAME AS EFFECTIVE INGREDIENT PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) 2017-05-11 — — US disclosed
US-20170129904-A1 NEW COMPOUND FOR INHIBITING BINDING BETWEEN DX2 PROTEIN AND P14/ARF PROTEIN, AND PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING CANCER DISEASE CONTAINING SAME AS EFFECTIVE INGREDIENT PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) 2017-05-11 — — US disclosed
EP-2001463-B1 A PHARMACEUTICAL COMPOSITION USEFUL AS ACETYL CHOLINESTERASE INHIBITORS COUNCIL SCIENT IND RES (IN) 2013-07-03 — — EP disclosed
EP-2001463-B1 A PHARMACEUTICAL COMPOSITION USEFUL AS ACETYL CHOLINESTERASE INHIBITORS COUNCIL SCIENT IND RES (IN) 2013-07-03 — — EP disclosed
CN-101437510-B A pharmaceutical composition useful as acetyl cholinesterase inhibitors COUNCIL SCIENT IND RES 2012-12-05 — — CN disclosed
US-20080009544-A1 Pharmaceutical Composition Useful as Acetylcholinesterase Inhibitors COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2008-01-10 — — US disclosed
US-20080009544-A1 Pharmaceutical Composition Useful as Acetylcholinesterase Inhibitors COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2008-01-10 — — US disclosed
WO-2007107846-A1 A PHARMACEUTICAL COMPOSITION USEFUL AS ACETYL CHOLINESTERASE INHIBITORS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2007-09-27 — — WO disclosed
WO-2007107846-A1 A PHARMACEUTICAL COMPOSITION USEFUL AS ACETYL CHOLINESTERASE INHIBITORS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2007-09-27 — — WO disclosed
WO-2007107846-A1 A PHARMACEUTICAL COMPOSITION USEFUL AS ACETYL CHOLINESTERASE INHIBITORS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2007-09-27 — — WO disclosed
US-5216176-A 7-alkoxycoumarins, dihydropsoralens, and benzodipyranones as photo-activated therapeutic agents and inhibitors of epidermal growth factor LEHIGH UNIVERSITY (US) 1993-06-01 — — US disclosed
WO-1990008529-A2 7-ALKOXYCOUMARINS, DIHYDROPSORALENS, AND BENZODIPYRANONES AS PHOTO-ACTIVATED THERAPEUTIC AGENTS AND INHIBITORS OF EPIDERMAL GROWTH FACTOR LEHIGH UNIVERSITY (US) 1990-08-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080009544-A1 Pharmaceutical Composition Useful as Acetylcholinesterase Inhibitors ACHE, BCHE, CHRNB1 GAA 489/4885ACHE 1/4885MGAM 1102/4885
US-20120277297-A1 Pharmaceutical Composition Useful as Acetylcholinesterase Inhibitors ACHE, BCHE, CYP3A7 GAA 440/4885ACHE 1/4885MGAM 2152/4885
US-20170129904-A1 NEW COMPOUND FOR INHIBITING BINDING BETWEEN DX2 PROTEIN AND P14/ARF PROTEIN, AND PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING CANCER DISEASE CONTAINING SAME AS EFFECTIVE INGREDIENT ARFIP2, G3BP2, TPX2 GAA 3451/4885ACHE 4685/4885MGAM 4732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback